BioTime, Inc. to Announce Fourth Quarter and Fiscal 2016 Results on March 16, 2017

07:17 EST 23 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
BioTime, Inc. (NYSE MKT:BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that it will release fourth quarter and fiscal 2016 financial and ope...

Other Sources for this Article

Investor Contact:
EVC Group, Inc.
Matt Haines, 917-733-9297
Brian Moore, 310-579-6199
Media Contact:
Gotham Communications, LLC
Bill Douglass, 646-504-0890


More From BioPortfolio on "BioTime, Inc. to Announce Fourth Quarter and Fiscal 2016 Results on March 16, 2017"

Quick Search


Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...